Two‐dimensional separations of the genome and proteome of neuroblastoma cells
- 1 January 1996
- journal article
- research article
- Published by Wiley in Electrophoresis
- Vol. 17 (11) , 1741-1751
- https://doi.org/10.1002/elps.1150171112
Abstract
Two‐dimensional (2‐D) electrophoretic methods have been available that allow separation of the protein constituents of a cell population. It has also become feasible to electrophoretically separate in two dimensions and to display DNA fragments derived from genomic digests. Through the appropriate choice of restriction enzymes, the functional component of the genome that encompasses CpG islands can be preferentially visualized in 2‐D gels. The same computerized approach for the analysis of 2‐D patterns can be applied to investigations at either the protein or DNA levels. Our group has utilized 2‐D electrophoresis to investigate both protein and DNA changes in cancer. The emphasis to date has been on the identification of proteins, the abundance of which is related to specific biological features of the tumors analyzed and of DNA fragments encompassed in genomic amplifications, as the latter commonly contain growth‐related genes. Findings derived from our analysis of neuroblastoma tumors and cell lines using 2‐D approaches are reviewed. Data for four proteins observed in 2‐D gels are presented because of our demonstrated association of these proteins with differentiation and proliferation properties of neuroblastoma. At the genomic level, the detection of amplifications using 2‐D gels has necessitated an understanding of the variability displayed by multi‐copy genomic fragments, which we have accomplished to a large part and which we present. An important benefit of 2‐D approaches is the efficiency of scale and the ease with which abundant proteins or multicopy genomic fragments can be detected, identified and quantitatively analyzed.Keywords
This publication has 56 references indexed in Scilit:
- Prognostic Value of Proliferating Cell Nuclear Antigen (PCNA) Immunostaining in NeuroblastomaMedical and Pediatric Oncology, 1995
- High yield of restriction fragment length polymorphisms in two-dimensional separations of human genomic DNAGenomics, 1995
- PCNA levels in neuroblastoma are increased in tumors with an amplified N-myc gene and in metastatic stage tumorsClinical & Experimental Metastasis, 1993
- Isolation of telomere junction fragments by anchored polymerase chain reactionProceedings Of The Royal Society B-Biological Sciences, 1992
- A two‐dimensional electrophoresis‐related laboratory information processing system: Spot matchingElectrophoresis, 1991
- Molecular consequences of awdb3, a cell-autonomous lethal mutation of Drosophila induced by hybrid dysgenesisDevelopmental Biology, 1988
- Gene amplification in human neuroblastomas: Basic mechanisms and clinical implicationsCancer Genetics and Cytogenetics, 1986
- Cellular DNA Content as a Predictor of Response to Chemotherapy in Infants with Unresectable NeuroblastomaNew England Journal of Medicine, 1984
- Chromosome analysis of human neuroblastoma cell line TR14 showing double minutes and an aberration involving chromosome 1Cancer Genetics and Cytogenetics, 1983
- Cell proliferation in neuroblastomaPublished by Elsevier ,1970